Author  
Place of duty  
Title   비소세포폐암 환자에서 Cisplatin 과 Vinorelbine 복합화학요법의 유용성 ( Combination Chemotherapy with Cisplatin and Vinorelbine in Patients with Non - Small - Cell Lung Cancer )
Publicationinfo   2000 Jan; 032(05): 911-918.
Key_word   Non-small-cell lung cancer, Chemotherapy, Vinorelbine, Cisplatin
Full-Text  
Abstract   Purpose: To determine the therapeutic effect and toxicities of cisplatin and vinorelbine combination chemotherapy in patients with inoperable non-small-cell lung cancer. Materials and Methods: Between Jan 1998 and Dec 1999, 28 patients with inoperable non- small-cell lung cancer were treated with cisplatin and vinorelbine combination chemotherapy as induction treatment. A combination of vinorelbine 25 mg/m2 day 1,8 and cisplatin 60 mg/m2 day 1 were giv0n and repeated every 3 weeks. Then we assessed response and toxicity according to WHO grades. Results: According to response criteria, there were 1 complete response, 12 partial response (42.9%), 12 stable disease (42.9%), and 3 progression (10.7%). The median survival was 12 months. According to toxicity grades, 24 grade 3 myelosuppression (24.7%), 12 grade 4 myelosuppression (10.7%), 6 grade 3 and 4 constipation (6.1%), and mild 7 (7.2%) thrombophlebitis were experienced in evaluable 97 cycles. There was no other clinically severe toxicity. Conclusion: These results suggest that combination chemotherapy with cisplatin and vinorelbine in patients with inoperable non-small-cell lung cancer was effective and safe.
저 자   김기원(Kee Won Kim),박석영(Suk Young Park),서지원(Ji Won Suhr),김승준(Seung Joon Kim),양동헌(Dong Hoen Yang),이은희(Eun Hee Lee),이경식(Kyung Shick Lee)